Selective NF-¿B inhibition versus dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model of acute lung injury - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pulmonary Pharmacology & Therapeutics Année : 2009

Selective NF-¿B inhibition versus dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model of acute lung injury

Philipp von Bismarck
  • Fonction : Auteur
Karsten Klemm
  • Fonction : Auteur
Supandi Winoto-Morbach
  • Fonction : Auteur
Stefan Schutze
  • Fonction : Auteur
Martin F. Krause
  • Fonction : Auteur correspondant
  • PersonId : 883315

Connectez-vous pour contacter l'auteur

Résumé

Acute respiratory failure in neonates (e.g., ARDS, meconium aspiration pneumonitis, pneumonia) is characterized by an excessive inflammatory response, governing the migration of polymorpho-nuclear leukocytes (PMNL) into lung tissue and causing consecutive impairment of gas exchange and lung function. Critical to this inflammatory response is the activation of nuclear factor-κB (NF-κB) that is required for transcription of the genes for many pro-inflammatory mediators. We asked whether the inhibition of NF-κB activity using either a selective inhibitor (IKK-NBD peptide) or dexamethasone would be more effective in decreasing NF-κB activity and chemokine expression in pulmonary cells. Changes in lung function were repeatedly assessed for 24h following induction of acute respiratory failure and therapeutic intervention.
Fichier principal
Vignette du fichier
PEER_stage2_10.1016%2Fj.pupt.2009.02.002.pdf (374.55 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00540031 , version 1 (26-11-2010)

Identifiants

Citer

Philipp von Bismarck, Karsten Klemm, Carlos-Francisco Garcia.Wistadt, Supandi Winoto-Morbach, Stefan Schutze, et al.. Selective NF-¿B inhibition versus dexamethasone, decreases acute lung injury in a newborn piglet airway inflammation model of acute lung injury. Pulmonary Pharmacology & Therapeutics, 2009, 22 (4), pp.297. ⟨10.1016/j.pupt.2009.02.002⟩. ⟨hal-00540031⟩

Collections

PEER
94 Consultations
128 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More